Correlation Between VentureNet Capital and ImmunoGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentureNet Capital and ImmunoGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentureNet Capital and ImmunoGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentureNet Capital Group and ImmunoGen, you can compare the effects of market volatilities on VentureNet Capital and ImmunoGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentureNet Capital with a short position of ImmunoGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentureNet Capital and ImmunoGen.

Diversification Opportunities for VentureNet Capital and ImmunoGen

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VentureNet and ImmunoGen is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding VentureNet Capital Group and ImmunoGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmunoGen and VentureNet Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentureNet Capital Group are associated (or correlated) with ImmunoGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmunoGen has no effect on the direction of VentureNet Capital i.e., VentureNet Capital and ImmunoGen go up and down completely randomly.

Pair Corralation between VentureNet Capital and ImmunoGen

If you would invest  0.01  in VentureNet Capital Group on August 24, 2024 and sell it today you would earn a total of  0.01  from holding VentureNet Capital Group or generate 100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy0.79%
ValuesDaily Returns

VentureNet Capital Group  vs.  ImmunoGen

 Performance 
       Timeline  
VentureNet Capital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentureNet Capital Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
ImmunoGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmunoGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, ImmunoGen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

VentureNet Capital and ImmunoGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentureNet Capital and ImmunoGen

The main advantage of trading using opposite VentureNet Capital and ImmunoGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentureNet Capital position performs unexpectedly, ImmunoGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmunoGen will offset losses from the drop in ImmunoGen's long position.
The idea behind VentureNet Capital Group and ImmunoGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities